Skip to content
Taxonomy
2021 STAR Accomplishments
With our community’s help, the CMTA has invested over $17.5 Read More
Initiation of Registrational Phase 2/3 Study of AT-007 in SORD Deficiency
Applied Therapeutics Announces Initiation of Registrational Phase 2/3 Study of Read More
CMTA Seed Money Draws NIH Support For Type 2 Gene Editing
CMTA Seed Money Draws NIH Support For Type 2 Gene Read More
CMTA-STAR Awards $354,826 for CMT Clinical Trial
CMTA-STAR Awards $354,826 for CMT Clinical Trial (Glenolden, PA, December Read More
CMT Subtype Biomarkers and Outcome Measures
CMT Subtype Biomarkers and Outcome Measures This study is a Read More
CMTA-STAR Awards Researcher $98,985 For CMT1A Project
CMTA-STAR Awards Researcher $98,985 For CMT1A Project Using Dental Pulp Read More
CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A
CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A (Glenolden, Read More
CMTA and Applied Therapeutics Announce Collaboration for CMT-SORD
CMTA and Applied Therapeutics Announce Collaboration for CMT-SORD (Glenolden, PA, Read More
Taysha Gene Therapies & CMTA Collaborate to Increase Genetic Testing Access for Giant Axonal Neuropathy (GAN)
Taysha Gene Therapies Announces Sponsored Genetic Testing for Giant Axonal Read More
CMTA and ToolGen Announce CMT1A Collaboration
CMTA and ToolGen Announce Collaboration to Develop Potential Treatment for Read More
